Related Experiment Videos
[Arguments against conventional balloon dilatation of recurrences within the stent]
1Abteilung Kardiologie, Zentrum Innere Medizin Universität-GHS Essen.
Insights
Stent restenosis remains a challenge in coronary stenting. Ablative techniques may offer better outcomes than balloon angioplasty for diffuse restenosis, but further trials are needed.
Area of Science:
- Interventional Cardiology
- Biomedical Engineering
- Vascular Biology
Background:
- Stent restenosis is a significant limitation following coronary stent implantation.
- Reported restenosis rates after coronary stenting vary widely (18-78%) depending on lesion type.
- Current treatments include repeat balloon angioplasty, ablative techniques, and stent-in-stent placement.
Purpose of the Study:
- To evaluate interventional treatment options for symptomatic stent restenosis.
- To compare the efficacy of different strategies for focal versus diffuse stent restenosis.
- To explore the pathophysiological basis for varying treatment outcomes.
Main Methods:
- Review of interventional treatment options for symptomatic stent restenosis.
- Comparison of restenosis rates for balloon angioplasty, ablative techniques, and stent-in-stent placement.
- Analysis of lesion characteristics (focal vs. diffuse) and their impact on outcomes.
Main Results:
- Long-term success for focal (<10 mm) stent restenosis is similar across strategies (approx. 30% restenosis).
- Diffuse (>10 mm) stent restenosis shows higher rates with balloon angioplasty (35-85%).
- Ablative techniques show promising lower restenosis rates (25-56%) compared to balloon angioplasty alone.
Conclusions:
- Balloon angioplasty has limitations in addressing neointimal tissue causing stent restenosis.
- Ablative techniques may create a more adequate lumen with less trauma, potentially leading to lower restenosis.
- Further prospective randomized trials are necessary to confirm the superiority of ablative techniques over balloon angioplasty for stent restenosis.
Abstract:
Today, stent restenosis is the major limitation of coronary stent implantation. Despite several prospective randomized trials, which documented significantly lower restenosis rates after stenting compared to conventional balloon angioplasty for the treatment of de-novo stenoses, restenotic lesions, bypass graft stenoses and symptomatic dissections, in daily clinical practice restenosis rates after coronary stenting are reported between 18% and 78% depending on the lesions treated. Interventional treatment options for symptomatic stent restenosis include repeat balloon angioplasty, a combination of ablative approaches (rotablation, laser angioplasty, directional atherectomy) with balloon angioplasty, and stent-in-stent (sandwich technique) placement. Long-term success for the treatment of focal (< or = 10 mm) stent restenosis seems to be equivalent for all these strategies with a restenosis rate of about 30% while after balloon angioplasty of diffuse (> 10 mm) stent restenosis restenosis rates range between 35% and 85%. From a pathophysiological point of view it seems conclusive that balloon angioplasty can only achieve a limited lumen by plastic deformation of the obstructive neointimal tissue, which is responsible for stent restenosis. In this situation techniques, which ablate the neointimal tissue, can create a more adequate lumen without extensive vessel trauma supported by lower restenosis rates between 25% and 56% compared to balloon angioplasty alone. Prospective randomized trial are needed in the future to support a superiority of ablative techniques over conventional balloon angioplasty for the treatment of stent restenosis.